TrialAmerican journal of respiratory and critical care medicine2022

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for

Marcus A Mall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.